{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:18:29Z","timestamp":1775189909845,"version":"3.50.1"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/nrneph.2014.173","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T12:04:40Z","timestamp":1412078680000},"page":"687-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["An approach to cystic kidney diseases: the clinician's view"],"prefix":"10.1038","volume":"10","author":[{"given":"Christine E.","family":"Kurschat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman-Ulrich","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Maintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Schermer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Benzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"key":"BFnrneph2014173_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.genom.7.080505.115610","volume":"7","author":"JL Badano","year":"2006","unstructured":"Badano, J. L., Mitsuma, N., Beales, P. L. & Katsanis, N. The ciliopathies: an emerging class of human genetic disorders. Annu. Rev. Genomics Hum. Genet. 7, 125\u2013148 (2006).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"BFnrneph2014173_CR2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nrm2278","volume":"8","author":"M Fliegauf","year":"2007","unstructured":"Fliegauf, M., Benzing, T. & Omran, H. When cilia go bad: cilia defects and ciliopathies. Nat. Rev. Mol. Cell Biol. 8, 880\u2013893 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneph2014173_CR3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cell.2009.03.023","volume":"137","author":"JM Gerdes","year":"2009","unstructured":"Gerdes, J. M., Davis, E. E. & Katsanis, N. The vertebrate primary cilium in development, homeostasis, and disease. Cell 137, 32\u201345 (2009).","journal-title":"Cell"},{"key":"BFnrneph2014173_CR4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMra1010172","volume":"364","author":"F Hildebrandt","year":"2011","unstructured":"Hildebrandt, F., Benzing, T. & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364, 1533\u20131543 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2014173_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/gm275","volume":"3","author":"JE Lee","year":"2011","unstructured":"Lee, J. E. & Gleeson, J. G. A systems-biology approach to understanding the ciliopathy disorders. Genome Med. 3, 59 (2011).","journal-title":"Genome Med."},{"key":"BFnrneph2014173_CR6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4161\/org.26766","volume":"10","author":"P Goggolidou","year":"2013","unstructured":"Goggolidou, P. Wnt and planar cell polarity signaling in cystic renal disease. Organogenesis 10, 86\u201395 (2013).","journal-title":"Organogenesis"},{"key":"BFnrneph2014173_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-genet-111212-133243","volume":"47","author":"S Yuan","year":"2013","unstructured":"Yuan, S. & Sun, Z. Expanding horizons: ciliary proteins reach beyond cilia. Annu. Rev. Genet. 47, 353\u2013376 (2013).","journal-title":"Annu. Rev. Genet."},{"key":"BFnrneph2014173_CR8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/humu.21337","volume":"31","author":"F Coppieters","year":"2010","unstructured":"Coppieters, F., Lefever, S., Leroy, B. P. & De Baere, E. CEP290, a gene with many faces: mutation overview and presentation of CEP290base. Hum. Mutat. 31, 1097\u20131108 (2010).","journal-title":"Hum. Mutat."},{"key":"BFnrneph2014173_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres, V. E. & Harris, P. C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149\u2013168 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2014173_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris, P. C. & Torres, V. E. Polycystic kidney disease. Annu. Rev. Med. 60, 321\u2013337 (2009).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph2014173_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0272-6386(12)80179-X","volume":"24","author":"JH Stewart","year":"1994","unstructured":"Stewart, J. H. End-stage renal failure appears earlier in men than in women with polycystic kidney disease. Am. J. Kidney Dis. 24, 181\u2013183 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014173_CR12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","volume":"375","author":"F Hildebrandt","year":"2010","unstructured":"Hildebrandt, F. Genetic kidney diseases. Lancet 375, 1287\u20131295 (2010).","journal-title":"Lancet"},{"key":"BFnrneph2014173_CR13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 1287\u20131301 (2007).","journal-title":"Lancet"},{"key":"BFnrneph2014173_CR14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/nm1207-1409","volume":"13","author":"E Kim","year":"2007","unstructured":"Kim, E. & Walz, G. Sensitive cilia set up the kidney. Nat. Med. 13, 1409\u20131411 (2007).","journal-title":"Nat. Med."},{"key":"BFnrneph2014173_CR15","doi-asserted-by":"crossref","unstructured":"Luciano, R. L. & Dahl, N. K. Extra-renal manifestations of ADPKD: considerations for routine screening and management. Nephrol. Dial. Transplant. 29, 247\u2013254.","DOI":"10.1093\/ndt\/gft437"},{"key":"BFnrneph2014173_CR16","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1681\/ASN.2006060603","volume":"17","author":"VE Torres","year":"2006","unstructured":"Torres, V. E. Water for ADPKD? Probably, yes. J. Am. Soc. Nephrol. 17, 2089\u20132091 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres, V. E. et al. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat. Med. 10, 363\u2013364 (2004).","journal-title":"Nat. Med."},{"key":"BFnrneph2014173_CR18","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","volume":"17","author":"S Nagao","year":"2006","unstructured":"Nagao, S. et al. Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J. Am. Soc. Nephrol. 17, 2220\u20132227 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR19","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","volume":"5","author":"S Klahr","year":"1995","unstructured":"Klahr, S. et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J. Am. Soc. Nephrol. 5, 2037\u20132047 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer, N. et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353, 103\u2013107 (1999).","journal-title":"Lancet"},{"key":"BFnrneph2014173_CR21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1172\/JCI40076","volume":"120","author":"JF O'Toole","year":"2010","unstructured":"O'Toole, J. F. et al. Individuals with mutations in XPNPEP3, which encodes a mitochondrial protein, develop a nephronophthisis-like nephropathy. J. Clin. Invest. 120, 791\u2013802 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014173_CR22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1681\/ASN.2012101034","volume":"24","author":"TW Hurd","year":"2013","unstructured":"Hurd, T. W. et al. Mutation of the Mg2+ transporter SLC41A1 results in a nephronophthisis-like phenotype. J. Am. Soc. Nephrol. 24, 967\u2013977 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0272-6386(12)70338-4","volume":"22","author":"D Ravine","year":"1993","unstructured":"Ravine, D., Gibson, R. N., Donlan, J. & Sheffield, L. J. An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases. Am. J. Kidney Dis. 22, 803\u2013807 (1993).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014173_CR24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/aps.2011.29","volume":"32","author":"Y Sun","year":"2011","unstructured":"Sun, Y., Zhou, H. & Yang, B. Drug discovery for polycystic kidney disease. Acta Pharmacol. Sin. 32, 805\u2013816 (2011).","journal-title":"Acta Pharmacol. Sin."},{"key":"BFnrneph2014173_CR25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.ejhg.5200484","volume":"8","author":"C Badenas","year":"2000","unstructured":"Badenas, C. et al. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients. Eur. J. Hum. Genet. 8, 487\u2013492 (2000).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneph2014173_CR26","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford, J. M. et al. The mTOR pathway is regulated by polycystin 1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA. 103, 5466\u20135471 (2006).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"BFnrneph2014173_CR27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","volume":"11","author":"K Hanaoka","year":"2000","unstructured":"Hanaoka, K. & Guggino, W. B. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J. Am. Soc. Nephrol. 11, 1179\u20131187 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI117638","volume":"95","author":"JJ Grantham","year":"1995","unstructured":"Grantham, J. J., Ye, M., Gattone, V. H. & Sullivan, L. P. In vitro fluid secretion by epithelium from polycystic kidneys. J. Clin. Invest. 95, 195\u2013202 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014173_CR29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","volume":"25","author":"VE Torres","year":"2014","unstructured":"Torres, V. E. & Harris, P. C. Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J. Am. Soc. Nephrol. 25, 18\u201332 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR30","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/ndt\/gfl150","volume":"21","author":"MY Chang","year":"2006","unstructured":"Chang, M. Y. et al. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol. Dial. Transplant. 21, 2078\u20132084 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014173_CR31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1681\/ASN.V84616","volume":"8","author":"MD Griffin","year":"1997","unstructured":"Griffin, M. D., Torres, V. E., Grande, J. P. & Kumar, R. Vascular expression of polycystin. J. Am. Soc. Nephrol. 8, 616\u2013626 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR32","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/ki.1997.444","volume":"52","author":"MD Griffin","year":"1997","unstructured":"Griffin, M. D. et al. Expression of polycystin in mouse metanephros and extra-metanephric tissues. Kidney Int. 52, 1196\u20131205 (1997).","journal-title":"Kidney Int."},{"key":"BFnrneph2014173_CR33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1378\/chest.08-1549","volume":"136","author":"J Wu","year":"2009","unstructured":"Wu, J. et al. Characterization of primary cilia in human airway smooth muscle cells. Chest 136, 561\u2013570 (2009).","journal-title":"Chest"},{"key":"BFnrneph2014173_CR34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2009.08.045","volume":"139","author":"R Sharif-Naeini","year":"2009","unstructured":"Sharif-Naeini, R. et al. Polycystin 1 and 2 dosage regulates pressure sensing. Cell 139, 587\u2013596 (2009).","journal-title":"Cell"},{"key":"BFnrneph2014173_CR35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1053\/j.gastro.2006.07.003","volume":"131","author":"AI Masyuk","year":"2006","unstructured":"Masyuk, A. I. et al. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology 131, 911\u2013920 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrneph2014173_CR36","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.1990.286","volume":"38","author":"JM Cobben","year":"1990","unstructured":"Cobben, J. M., Breuning, M. H., Schoots, C., ten Kate, L. P. & Zerres, K. Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease. Kidney Int. 38, 880\u2013885 (1990).","journal-title":"Kidney Int."},{"key":"BFnrneph2014173_CR37","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","volume":"4","author":"GM Fick","year":"1994","unstructured":"Fick, G. M. et al. The spectrum of autosomal dominant polycystic kidney disease in children. J. Am. Soc. Nephrol. 4, 1654\u20131660 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR38","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1681\/ASN.2006080835","volume":"17","author":"PC Harris","year":"2006","unstructured":"Harris, P. C. et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 17, 3013\u20133019 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","volume":"39","author":"GM Fick-Brosnahan","year":"2002","unstructured":"Fick-Brosnahan, G. M., Belz, M. M., McFann, K. K., Johnson, A. M. & Schrier, R. W. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am. J. Kidney Dis. 39, 1127\u20131134 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014173_CR40","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","volume":"8","author":"AM Johnson","year":"1997","unstructured":"Johnson, A. M. & Gabow, P. A. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J. Am. Soc. Nephrol. 8, 1560\u20131567 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","volume":"6","author":"VE Torres","year":"2011","unstructured":"Torres, V. E. et al. Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 640\u2013647 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR42","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/gfu093","volume":"29","author":"E Higashihara","year":"2014","unstructured":"Higashihara, E. et al. Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease? Nephrol. Dial. Transplant. 29, 1710\u20131719 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014173_CR43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0272-6386(03)00193-8","volume":"41","author":"LA Hebert","year":"2003","unstructured":"Hebert, L. A., Greene, T., Levey, A., Falkenhain, M. E. & Klahr, S. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am. J. Kidney Dis. 41, 962\u2013971 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014173_CR44","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","volume":"343","author":"D Ravine","year":"1994","unstructured":"Ravine, D. et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343, 824\u2013827 (1994).","journal-title":"Lancet"},{"key":"BFnrneph2014173_CR45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1148\/radiology.213.1.r99oc05273","volume":"213","author":"C Nicolau","year":"1999","unstructured":"Nicolau, C. et al. Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. Radiology 213, 273\u2013276 (1999).","journal-title":"Radiology"},{"key":"BFnrneph2014173_CR46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei, Y. et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J. Am. Soc. Nephrol. 20, 205\u2013212 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2215\/CJN.00900112","volume":"7","author":"JJ Grantham","year":"2012","unstructured":"Grantham, J. J. et al. Detected renal cysts are tips of the iceberg in adults with ADPKD. Clin. J. Am. Soc. Nephrol. 7, 1087\u20131093 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR48","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/ndt\/gfr467","volume":"27","author":"B Orskov","year":"2012","unstructured":"Orskov, B., S\u00f8rensen, V. R., Feldt-Rasmussen, B. & Strandgaard, S. Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol. Dial. Transplant. 27, 1607\u20131613 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014173_CR49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","volume":"94","author":"FJ O'Callaghan","year":"2004","unstructured":"O'Callaghan, F. J., Noakes, M. J., Martyn, C. N. & Osborne, J. P. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int. 94, 853\u2013857 (2004).","journal-title":"BJU Int."},{"key":"BFnrneph2014173_CR50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin","year":"2002","unstructured":"Kaelin, W. G. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer 2, 673\u2013682 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnrneph2014173_CR51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MNH.0b013e3283622b86","volume":"22","author":"G Gambaro","year":"2013","unstructured":"Gambaro, G., Danza, F. M. & Fabris, A. Medullary sponge kidney. Curr. Opin. Nephrol. Hypertens. 22, 421\u2013426 (2013).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2014173_CR52","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/ndt\/gfs505","volume":"28","author":"A Fabris","year":"2013","unstructured":"Fabris, A., Anglani, F., Lupo, A. & Gambaro, G. Medullary sponge kidney: state of the art. Nephrol. Dial. Transplant. 28, 1111\u20131119 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014173_CR53","first-page":"1282","volume":"26","author":"R Sherstha","year":"1997","unstructured":"Sherstha, R. et al. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 26, 1282\u20131286 (1997).","journal-title":"Hepatology"},{"key":"BFnrneph2014173_CR54","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3748\/wjg.v12.i22.3537","volume":"12","author":"D Alvaro","year":"2006","unstructured":"Alvaro, D. et al. Estrogens and the pathophysiology of the biliary tree. World J. Gastroenterol. 12, 3537\u20133545 (2006).","journal-title":"World J. Gastroenterol."},{"key":"BFnrneph2014173_CR55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0272-6386(99)70117-4","volume":"34","author":"ER Stamm","year":"1999","unstructured":"Stamm, E. R. et al. Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 34, 120\u2013124 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014173_CR56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3174\/ajnr.A3437","volume":"35","author":"MN Rozenfeld","year":"2014","unstructured":"Rozenfeld, M. N. et al. Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms? Am. J. Neuroradiol. 35, 3\u20139 (2014).","journal-title":"Am. J. Neuroradiol."},{"key":"BFnrneph2014173_CR57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1681\/ASN.V131269","volume":"13","author":"Y Pirson","year":"2002","unstructured":"Pirson, Y., Chauveau, D. & Torres, V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 13, 269\u2013276 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/STROKEAHA.110.578740","volume":"42","author":"HW Xu","year":"2011","unstructured":"Xu, H. W., Yu, S. Q., Mei, C. L. & Li, M. H. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 42, 204\u2013206 (2011).","journal-title":"Stroke"},{"key":"BFnrneph2014173_CR59","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2215\/CJN.09731110","volume":"6","author":"MV Irazabal","year":"2011","unstructured":"Irazabal, M. V. et al. Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 1274\u20131285 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR60","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM198810063191404","volume":"319","author":"KF Hossack","year":"1988","unstructured":"Hossack, K. F., Leddy, C. L., Johnson, A. M., Schrier, R. W. & Gabow, P. A. Echocardiographic findings in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 319, 907\u2013912 (1988).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2014173_CR61","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","volume":"5","author":"GM Fick","year":"1995","unstructured":"Fick, G. M., Johnson, A. M., Hammond, W. S. & Gabow, P. A. Causes of death in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 5, 2048\u20132056 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR62","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.10.5.336","volume":"10","author":"LE Hughes","year":"1969","unstructured":"Hughes, L. E. Postmortem survey of diverticular disease of the colon. I. Diverticulosis and diverticulitis. Gut 10, 336\u2013344 (1969).","journal-title":"Gut"},{"key":"BFnrneph2014173_CR63","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1542\/peds.111.5.1072","volume":"111","author":"LM Guay-Woodford","year":"2003","unstructured":"Guay-Woodford, L. M. & Desmond, R. A. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111, 1072\u20131080 (2003).","journal-title":"Pediatrics"},{"key":"BFnrneph2014173_CR64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/humu.20029","volume":"23","author":"C Bergmann","year":"2004","unstructured":"Bergmann, C. et al. PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum. Mutat. 23, 453\u2013463 (2004).","journal-title":"Hum. Mutat."},{"key":"BFnrneph2014173_CR65","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/ndt\/16.8.1648","volume":"16","author":"C Fonck","year":"2001","unstructured":"Fonck, C., Chauveau, D., Gagnadoux, M. F., Pirson, Y. & Gr\u00fcnfeld, J. P. Autosomal recessive polycystic kidney disease in adulthood. Nephrol. Dial. Transplant. 16, 1648\u20131652 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2014173_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","volume":"85","author":"M Adeva","year":"2006","unstructured":"Adeva, M. et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) 85, 1\u201321 (2006).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph2014173_CR67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00467-010-1656-1","volume":"26","author":"WE Sweeney Jr","year":"2011","unstructured":"Sweeney, W. E., Jr & Avner, E. D. Diagnosis and management of childhood polycystic kidney disease. Pediatr. Nephrol. 26, 675\u2013692 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2014173_CR68","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1034\/j.1600-6143.2002.20412.x","volume":"2","author":"K Khan","year":"2002","unstructured":"Khan, K., Schwarzenberg, S. J., Sharp, H. L., Matas, A. J. & Chavers, B. M. Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease. Am. J. Transplant. 2, 360\u2013365 (2002).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2014173_CR69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/02841859909175581","volume":"40","author":"S Kern","year":"1999","unstructured":"Kern, S., Zimmerhackl, L. B., Hildebrandt, F. & Uhl, M. Rare MR urography- a new diagnostic method in autosomal recessive polycystic kidney disease. Acta Radiol. 40, 543\u2013544 (1999).","journal-title":"Acta Radiol."},{"key":"BFnrneph2014173_CR70","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1651-2227.1996.tb14056.x","volume":"85","author":"K Zerres","year":"1996","unstructured":"Zerres, K. et al. Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische, Nephrologie. Acta Paediatr. 85, 437\u2013445 (1996).","journal-title":"Acta Paediatr."},{"key":"BFnrneph2014173_CR71","doi-asserted-by":"publisher","unstructured":"B\u00fcscher, R. et al. Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non kidney related phenotypes. Pediatr. Nephrol. (2013). http:\/\/dx.doi.org\/10.1007\/s004670132634-1 .","DOI":"10.1007\/s004670132634-1"},{"key":"BFnrneph2014173_CR72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.2008050456","volume":"20","author":"F Hildebrandt","year":"2009","unstructured":"Hildebrandt, F., Attanasio, M. & Otto, E. Nephronophthisis: Disease Mechanisms of a Ciliopathy. J. Am. Soc. Nephrol. 20, 23\u201335 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR73","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1681\/ASN.2006121344","volume":"18","author":"F Hildebrandt","year":"2007","unstructured":"Hildebrandt, F. & Zhou, W. Nephronophthisis-Associated Ciliopathies. J. Am. Soc. Nephrol. 18, 1855\u20131871 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR74","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00467-008-0840-z","volume":"24","author":"R Salomon","year":"2009","unstructured":"Salomon, R., Saunier, S. & Niaudet, P. Nephronophthisis. Pediatr. Nephrol. 24, 2333\u20132344 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2014173_CR75","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrg1727","volume":"6","author":"F Hildebrandt","year":"2005","unstructured":"Hildebrandt, F. & Otto, E. Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nat. Rev. Genet. 6, 928\u2013940 (2005).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrneph2014173_CR76","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00467-010-1585-z","volume":"26","author":"MTF Wolf","year":"2011","unstructured":"Wolf, M. T. F. & Hildebrandt, F. Nephronophthisis. Pediatr. Nephrol. 26, 181\u2013194 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2014173_CR77","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00439-013-1297-0","volume":"132","author":"J Halbritter","year":"2013","unstructured":"Halbritter, J. et al. Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathy. Hum. Genet. 132, 865\u2013884 (2013).","journal-title":"Hum. Genet."},{"key":"BFnrneph2014173_CR78","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81705-5","volume":"95","author":"S Nonaka","year":"1998","unstructured":"Nonaka, S. et al. Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell 95, 829\u2013837 (1998).","journal-title":"Cell"},{"key":"BFnrneph2014173_CR79","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1172\/JCI4786","volume":"102","author":"J Chen","year":"1998","unstructured":"Chen, J., Knowles, H. J., Hebert, J. L. & Hackett, B. P. Mutation of the mouse hepatocyte nuclear factor\/forkhead homologue 4 gene results in an absence of cilia and random left-right asymmetry. J. Clin. Invest. 102, 1077\u20131082 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014173_CR80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/1096-8628(200024)97:4<258::AID-AJMG1276>3.0.CO;2-8","volume":"97","author":"H Schneider","year":"2000","unstructured":"Schneider, H. & Brueckner, M. Of mice and men: dissecting the genetic pathway that controls left-right asymmetry in mice and humans. Am. J. Med. Genet. 97, 258\u2013270 (2000).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrneph2014173_CR81","first-page":"828","volume":"136","author":"R Betz","year":"2000","unstructured":"Betz, R. et al. Children with ocular motor apraxia type Cogan carry deletions in the gene (NPHP1) for juvenile nephronophthisis. J. Pediatr. 136, 828\u2013831 (2000).","journal-title":"J. Pediatr."},{"key":"BFnrneph2014173_CR82","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.40.5.311","volume":"40","author":"CA Johnson","year":"2003","unstructured":"Johnson, C. A. Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes. J. Med. Genet. 40, 311\u2013319 (2003).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2014173_CR83","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0002-9343(70)80051-1","volume":"49","author":"F Mainzer","year":"1970","unstructured":"Mainzer, F., Saldino, R. M., Ozonoff, M. B. & Minagi, H. Familial nephropathy associated with retinitis pigmentosa, cerebellar ataxia and skeletal abnormalities. Am. J. Med. 49, 556\u2013562 (1970).","journal-title":"Am. J. Med."},{"key":"BFnrneph2014173_CR84","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ajhg.2013.09.012","volume":"93","author":"J Halbritter","year":"2013","unstructured":"Halbritter, J. et al. Defects in the IFT B component IFT172 cause Jeune and Mainzer-Saldino syndromes in humans. Am. J. Hum. Genet. 93, 915\u2013925 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014173_CR85","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajhg.2013.06.022","volume":"93","author":"AM McInerney-Leo","year":"2013","unstructured":"McInerney-Leo, A. M. et al. Short-rib polydactyly and Jeune syndromes are caused by mutations in WDR60. Am. J. Hum. Genet. 93, 515\u2013523 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014173_CR86","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ajhg.2013.10.007","volume":"93","author":"C Huber","year":"2013","unstructured":"Huber, C. et al. WDR34 mutations that cause short-rib polydactyly syndrome type III\/severe asphyxiating thoracic dysplasia reveal a role for the NF\u03baB pathway in cilia. Am. J. Hum. Genet. 93, 926\u2013931 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014173_CR87","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/ajmg.a.36265","volume":"161","author":"AE Lin","year":"2013","unstructured":"Lin, A. E. et al. Sensenbrenner syndrome (Cranioectodermal dysplasia): clinical and molecular analyses of 39 patients including two new patients. Am. J. Med. Genet. A 161, 2762\u20132776 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrneph2014173_CR88","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ajmg.c.30229","volume":"151","author":"MA Parisi","year":"2009","unstructured":"Parisi, M. A. Clinical and molecular features of Joubert syndrome and related disorders. Am. J. Med. Genet. C Semin. Med. Genet. 151, 326\u2013340 (2009).","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"BFnrneph2014173_CR89","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-5-20","volume":"5","author":"F Brancati","year":"2010","unstructured":"Brancati, F., Dallapiccola, B. & Valente, E. M. Joubert Syndrome and related disorders. Orphanet J. Rare Dis. 5, 20 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFnrneph2014173_CR90","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1172\/JCI43639","volume":"121","author":"C Dafinger","year":"2011","unstructured":"Dafinger, C. et al. Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and microtubule dynamics. J. Clin. Invest. 121, 2662\u20132667 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014173_CR91","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(96)90513-2","volume":"27","author":"D O'Dea","year":"1996","unstructured":"O'Dea, D. et al. The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am. J. Kidney Dis. 27, 776\u2013783 (1996).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014173_CR92","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.03320410","volume":"6","author":"O Imhoff","year":"2011","unstructured":"Imhoff, O. et al. Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort. Clin. J. Am. Soc. Nephrol. 6, 22\u201329 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00467-010-1751-3","volume":"27","author":"A Putoux","year":"2012","unstructured":"Putoux, A., Attie-Bitach, T., Martinovic, J. & Gubler, M. C. Phenotypic variability of Bardet-Biedl syndrome: focusing on the kidney. Pediatr. Nephrol. 27, 7\u201315 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2014173_CR94","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00431-011-1553-z","volume":"171","author":"C Bergmann","year":"2012","unstructured":"Bergmann, C. Educational paper: ciliopathies. Eur. J. Pediatr. 171, 1285\u20131300 (2012).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrneph2014173_CR95","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1172\/JCI37041","volume":"119","author":"NA Zaghloul","year":"2009","unstructured":"Zaghloul, N. A. & Katsanis, N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J. Clin. Invest. 119, 428\u2013437 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2014173_CR96","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2215\/CJN.01220211","volume":"6","author":"G Boll\u00e9e","year":"2011","unstructured":"Boll\u00e9e, G. et al. Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clin. J. Am. Soc. Nephrol. 6, 2429\u20132438 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR97","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1046\/j.1523-1755.2003.00269.x","volume":"64","author":"MTF Wolf","year":"2003","unstructured":"Wolf, M. T. F. et al. Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains. Kidney Int. 64, 1580\u20131587 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2014173_CR98","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1086\/302414","volume":"64","author":"F Scolari","year":"1999","unstructured":"Scolari, F. et al. Identification of a new locus for medullary cystic disease, on chromosome 16p12. Am. J. Hum. Genet. 64, 1655\u20131660 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014173_CR99","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/01.ASN.0000092147.83480.B5","volume":"14","author":"K Dahan","year":"2003","unstructured":"Dahan, K. et al. A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J. Am. Soc. Nephrol. 14, 2883\u20132893 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR100","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/7.5.905","volume":"7","author":"K Christodoulou","year":"1998","unstructured":"Christodoulou, K. et al. Chromosome 1 localization of a gene for autosomal dominant medullary cystic kidney disease. Hum. Mol. Genet. 7, 905\u2013911 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014173_CR101","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jmg.39.12.882","volume":"39","author":"TC Hart","year":"2002","unstructured":"Hart, T. C. et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J. Med. Genet. 39, 882\u2013892 (2002).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2014173_CR102","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2543","volume":"45","author":"A Kirby","year":"2013","unstructured":"Kirby, A. et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat. Genet. 45, 299\u2013303 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014173_CR103","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ajhg.2009.07.010","volume":"85","author":"M Zivn\u00e1","year":"2009","unstructured":"Zivn\u00e1, M. et al. Dominant Renin Gene Mutations Associated with Early-Onset Hyperuricemia, Anemia, and Chronic Kidney Failure. Am. J. Hum. Genet. 85, 204\u2013213 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014173_CR104","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne, J. P., Fryer, A. & Webb, D. Epidemiology of tuberous sclerosis. Ann. N. Y. Acad. Sci. 615, 125\u2013127 (1991).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFnrneph2014173_CR105","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino, P. B., Nathanson, K. L. & Henske, E. P. The tuberous sclerosis complex. N. Engl. J. Med. 355, 1345\u20131356 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2014173_CR106","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jmg.33.6.480","volume":"33","author":"JA Cook","year":"1996","unstructured":"Cook, J. A., Oliver, K., Mueller, R. F. & Sampson, J. A cross sectional study of renal involvement in tuberous sclerosis. J. Med. Genet. 33, 480\u2013484 (1996).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2014173_CR107","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski, S. K. et al. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int. 70, 1777\u20131782 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph2014173_CR108","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd, C. W., Gomez, M. R., Lie, J. T. & Crowson, C. S. Causes of death in patients with tuberous sclerosis. Mayo Clin. Proc. 66, 792\u2013796 (1991).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrneph2014173_CR109","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-4295(91)80261-5","volume":"37","author":"R Washecka","year":"1991","unstructured":"Washecka, R. & Hanna, M. Malignant renal tumors in tuberous sclerosis. Urology 37, 340\u2013343 (1991).","journal-title":"Urology"},{"key":"BFnrneph2014173_CR110","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay, J. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer 49, 1374\u20131403 (2013).","journal-title":"Eur. J. Cancer"},{"key":"BFnrneph2014173_CR111","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yebeh.2008.05.010","volume":"13","author":"CMC Kopp","year":"2008","unstructured":"Kopp, C. M. C., Muzykewicz, D. A., Staley, B. A., Thiele, E. A. & Pulsifer, M. B. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behav. 13, 505\u2013510 (2008).","journal-title":"Epilepsy Behav."},{"key":"BFnrneph2014173_CR112","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","volume":"33","author":"C Joinson","year":"2003","unstructured":"Joinson, C. et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol. Med. 33, 335\u2013344 (2003).","journal-title":"Psychol. Med."},{"key":"BFnrneph2014173_CR113","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0387-7604(01)00304-7","volume":"23","author":"M Mizuguchi","year":"2001","unstructured":"Mizuguchi, M. & Takashima, S. Neuropathology of tuberous sclerosis. Brain Dev. 23, 508\u2013515 (2001).","journal-title":"Brain Dev."},{"key":"BFnrneph2014173_CR114","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/adc.2011.211995","volume":"96","author":"JRW Yates","year":"2011","unstructured":"Yates, J. R. W. et al. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch. Dis. Child. 96, 1020\u20131025 (2011).","journal-title":"Arch. Dis. Child."},{"key":"BFnrneph2014173_CR115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","volume":"173","author":"JH Ryu","year":"2006","unstructured":"Ryu, J. H. et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am. J. Respir. Crit. Care Med. 173, 105\u2013111 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2014173_CR116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1996.tb03597.x","volume":"135","author":"DW Webb","year":"1996","unstructured":"Webb, D. W., Clarke, A., Fryer, A. & Osborne, J. P. The cutaneous features of tuberous sclerosis: a population study. Br. J. Dermatol. 135, 1\u20135 (1996).","journal-title":"Br. J. Dermatol."},{"key":"BFnrneph2014173_CR117","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M Van Slegtenhorst","year":"1997","unstructured":"Van Slegtenhorst, M. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805\u2013808 (1997).","journal-title":"Science"},{"key":"BFnrneph2014173_CR118","doi-asserted-by":"crossref","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305\u20131315 (1993).","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"BFnrneph2014173_CR119","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mrrev.2008.01.001","volume":"658","author":"M Rosner","year":"2008","unstructured":"Rosner, M., Hanneder, M., Siegel, N., Valli, A. & Hengstschl\u00e4ger, M. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat. Res. 658, 234\u2013246 (2008).","journal-title":"Mutat. Res."},{"key":"BFnrneph2014173_CR120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00467-010-1689-5","volume":"26","author":"BJ Siroky","year":"2010","unstructured":"Siroky, B. J., Yin, H. & Bissler, J. J. Clinical and Molecular Insights into Tuberous Sclerosis Complex Renal Disease. Pediatr. Nephrol. 26, 839\u2013852 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2014173_CR121","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","volume":"130","author":"DF Lee","year":"2007","unstructured":"Lee, D. F. et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440\u2013455 (2007).","journal-title":"Cell"},{"key":"BFnrneph2014173_CR122","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler, J. J. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358, 140\u2013151 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2014173_CR123","unstructured":"FDA approval for Everolimus, US National Cancer Institute, [online] , (2014)."},{"key":"BFnrneph2014173_CR124","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11910-012-0269-4","volume":"12","author":"DN Franz","year":"2012","unstructured":"Franz, D. N. & Weiss, B. D. Molecular therapies for tuberous sclerosis and neurofibromatosis. Curr. Neurol. Neurosci. Rep. 12, 294\u2013301 (2012).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnrneph2014173_CR125","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/hmg\/6.12.2155","volume":"6","author":"AC Jones","year":"1997","unstructured":"Jones, A. C. et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum. Mol. Genet. 6, 2155\u20132161 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2014173_CR126","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter, P. T. et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease- a contiguous gene syndrome. Nat. Genet. 8, 328\u2013332 (1994).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014173_CR127","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneph.2013.144","volume":"9","author":"B Bausch","year":"2013","unstructured":"Bausch, B. et al. Renal cancer in von Hippel-Lindau disease and related syndromes. Nat. Rev. Nephrol. 9, 529\u2013538 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2014173_CR128","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","volume":"337","author":"HP Neumann","year":"1991","unstructured":"Neumann, H. P. & Wiestler, O. D. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 337, 1052\u20131054 (1991).","journal-title":"Lancet"},{"key":"BFnrneph2014173_CR129","first-page":"S119","volume":"19","author":"D Molino","year":"2006","unstructured":"Molino, D., Sepe, J., Anastasio, P. & De Santo, N. G. The history of von Hippel-Lindau disease. J. Nephrol. 19, S119\u2013S123 (2006).","journal-title":"J. Nephrol."},{"key":"BFnrneph2014173_CR130","first-page":"2299","volume":"56","author":"G Siemeister","year":"1996","unstructured":"Siemeister, G. et al. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res. 56, 2299\u20132301 (1996).","journal-title":"Cancer Res."},{"key":"BFnrneph2014173_CR131","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher, E. R., Neumann, H. P. & Richard, S. von Hippel-Lindau disease: a clinical and scientific review. Eur. J. Hum. Genet. 19, 617\u2013623 (2011).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneph2014173_CR132","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"77","author":"ER Maher","year":"1990","unstructured":"Maher, E. R. et al. Clinical features and natural history of von Hippel-Lindau disease. Q. J. Med. 77, 1151\u20131163 (1990).","journal-title":"Q. J. Med."},{"key":"BFnrneph2014173_CR133","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(98)01041-1","volume":"352","author":"NJ Vogelzang","year":"1998","unstructured":"Vogelzang, N. J. & Stadler, W. M. Kidney cancer. Lancet 352, 1691\u20131696 (1998).","journal-title":"Lancet"},{"key":"BFnrneph2014173_CR134","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser, R. R. et al. von Hippel-Lindau disease. Lancet 361, 2059\u20132067 (2003).","journal-title":"Lancet"},{"key":"BFnrneph2014173_CR135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.33.2.120","volume":"33","author":"IR Maddock","year":"1996","unstructured":"Maddock, I. R. et al. A genetic register for von Hippel-Lindau disease. J. Med. Genet. 33, 120\u2013127 (1996).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2014173_CR136","doi-asserted-by":"publisher","unstructured":"Bergmann, C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr. Nephrol. (2014). http:\/\/dx.doi.org\/10.1007\/s004670132706-2 .","DOI":"10.1007\/s004670132706-2"},{"key":"BFnrneph2014173_CR137","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneph.2010.18","volume":"6","author":"PC Harris","year":"2010","unstructured":"Harris, P. C. & Rossetti, S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat. Rev. Nephrol. 6, 197\u2013206 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2014173_CR138","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00439-013-1378-0","volume":"133","author":"YM Woo","year":"2014","unstructured":"Woo, Y. M. et al. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development. Hum. Genet. 133, 281\u2013297 (2014).","journal-title":"Hum. Genet."},{"key":"BFnrneph2014173_CR139","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0888-7543(95)80020-M","volume":"25","author":"MC Daoust","year":"1995","unstructured":"Daoust, M. C., Reynolds, D. M., Bichet, D. G. & Somlo, S. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25, 733\u2013736 (1995).","journal-title":"Genomics"},{"key":"BFnrneph2014173_CR140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00214191","volume":"96","author":"S De Almeida","year":"1995","unstructured":"De Almeida, S. et al. Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family. Hum. Genet. 96, 83\u201388 (1995).","journal-title":"Hum. Genet."},{"key":"BFnrneph2014173_CR141","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jmg.2005.032854","volume":"43","author":"EL Edghill","year":"2006","unstructured":"Edghill, E. L., Bingham, C., Ellard, S. & Hattersley, A. T. Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J. Med. Genet. 43, 84\u201390 (2006).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2014173_CR142","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/j.ajkd.2007.06.016","volume":"50","author":"S Faguer","year":"2007","unstructured":"Faguer, S. et al. Massively enlarged polycystic kidneys in monozygotic twins with TCF2\/HNF-1beta (hepatocyte nuclear factor-1beta) heterozygous whole-gene deletion. Am. J. Kidney Dis. 50, 1023\u20131027 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2014173_CR143","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.20141","volume":"39","author":"JPH Drenth","year":"2004","unstructured":"Drenth, J. P. H. et al. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Hepatology 39, 924\u2013931 (2004).","journal-title":"Hepatology"},{"key":"BFnrneph2014173_CR144","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","volume":"36","author":"S Davila","year":"2004","unstructured":"Davila, S. et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat. Genet. 36, 575\u2013577 (2004).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014173_CR145","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","volume":"70","author":"LF Onuchic","year":"2002","unstructured":"Onuchic, L. F. et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin transcription factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet. 70, 1305\u20131317 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2014173_CR146","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","volume":"30","author":"CJ Ward","year":"2002","unstructured":"Ward, C. J. et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 30, 259\u2013269 (2002).","journal-title":"Nat. Genet."},{"key":"BFnrneph2014173_CR147","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2009.440","volume":"77","author":"E Denamur","year":"2010","unstructured":"Denamur, E. et al. Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease. Kidney Int. 77, 350\u2013358 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2014173_CR148","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1681\/ASN.2007010125","volume":"18","author":"S Rossetti","year":"2007","unstructured":"Rossetti, S. & Harris, P. C. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J. Am. Soc. Nephrol. 18, 1374\u20131380 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR149","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/01.ASN.0000078805.87038.05","volume":"14","author":"L Furu","year":"2003","unstructured":"Furu, L. et al. Milder presentation of recessive polycystic kidney disease requires presence of amino acid substitution mutations. J. Am. Soc. Nephrol. 14, 2004\u20132014 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.ASN.0000039578.55705.6E","volume":"14","author":"C Bergmann","year":"2003","unstructured":"Bergmann, C. et al. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD\/PKHD1). J. Am. Soc. Nephrol. 14, 76\u201389 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2014173_CR151","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1523-1755.2003.00111.x","volume":"64","author":"S Rossetti","year":"2003","unstructured":"Rossetti, S. et al. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int. 64, 391\u2013403 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2014173_CR152","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymgme.2003.10.010","volume":"81","author":"PC Harris","year":"2004","unstructured":"Harris, P. C. & Rossetti, S. Molecular genetics of autosomal recessive polycystic kidney disease. Mol. Genet. Metab. 81, 75\u201385 (2004).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrneph2014173_CR153","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S1474-4422(13)70136-4","volume":"12","author":"M Romani","year":"2013","unstructured":"Romani, M., Micalizzi, A. & Valente, E. M. Joubert syndrome: congenital cerebellar ataxia with the molar tooth. Lancet Neurol. 12, 894\u2013905 (2013).","journal-title":"Lancet Neurol."},{"key":"BFnrneph2014173_CR154","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4161\/org.27375","volume":"10","author":"AR Barker","year":"2014","unstructured":"Barker, A. R., Thomas, R. & Dawe, H. R. Meckel-Gruber syndrome and the role of primary cilia in kidney, skeleton, and central nervous system development. Organogenesis 10, 96\u2013107 (2014).","journal-title":"Organogenesis"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.173","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:43:57Z","timestamp":1684471437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2014.173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":154,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["BFnrneph2014173"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2014.173","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]},"assertion":[{"value":"30 September 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}